BioPartners has extensive experience executing infectious disease studies, including diagnostic validation programs, respiratory and non-respiratory multi-swab studies, comparative device performance evaluations, and large-scale biospecimen procurement.

We support studies involving viral, bacterial, and fungal pathogens, offering controlled workflows for swab collection, blood draws, stool samples, saliva, and other specimen types. Our teams adhere to strict biosafety protocols and standardized sample-handling procedures designed to maintain the stability, accuracy, and reliability of sensitive analytes.

Our infectious disease capabilities are strengthened by access to diverse symptomatic and asymptomatic populations, enabling efficient enrollment for studies requiring matched swabs, serial sampling, or seasonally dependent recruitment. We work closely with sponsors developing point-of-care tests, molecular assays, multiplex platforms, and rapid diagnostics.

BioPartners’ infrastructure ensures accurate labeling, temperature-controlled transport, adherence to IATA regulations, and seamless communication throughout the study lifecycle.

Our operational expertise produces high-quality results that support assay validation, regulatory submissions, and large commercial diagnostic launches.